首页 | 本学科首页   官方微博 | 高级检索  
检索        

硫辛酸联合前列地尔治疗2型糖尿病周围神经病变30例
引用本文:符春辉,李秋实.硫辛酸联合前列地尔治疗2型糖尿病周围神经病变30例[J].药品评价,2021(1):62-64.
作者姓名:符春辉  李秋实
作者单位:宁都县人民医院
摘    要:目的:探究硫辛酸联合前列地尔治疗2型糖尿病(T2MD)合并周围神经病变的疗效.方法:选取宁都县人民医院2017年5月至2019年11月收治的60例T2MD合并周围神经病变患者,按照单双号法将60例患者平均分为对照组与观察组,均控制血糖治疗,其中对照组加用前列地尔治疗,观察组加用硫辛酸联合前列地尔治疗,两组患者均连续用药...

关 键 词:糖尿病神经病变  糖尿病  2型  硫辛酸  前列地尔

Lipoic Acid Combined with Alprostadil in the Treatment of 30 Cases of Type 2 Diabetes Mellitus with Peripheral Neuropathy
FU Chunhui,LI Qiushi.Lipoic Acid Combined with Alprostadil in the Treatment of 30 Cases of Type 2 Diabetes Mellitus with Peripheral Neuropathy[J].Drug Evaluation,2021(1):62-64.
Authors:FU Chunhui  LI Qiushi
Institution:(Ningdu County People's Hospital,Ningdu Jiangxi 342800,China)
Abstract:Objective:To investigate the efficacy of Lipoic acid combined with Alprostadil in the treatment of type 2 diabetes mellitus(T2MD)with peripheral neuropathy.Methods:Sixty patients with T2MD complicated with peripheral neuropathy admitted to Ningdu County People’s Hospital were selected between May 2017 and November 2019,and the 60 patients were evenly divided into the control group and the observation group according to the odd-even number method.All the patients were given blood glucose control therapy,and the control group was additionally treated with Alprostadil,and the observation group was treated with Lipoic acid combined with Alprostadil.The total clinical effective rate of the two groups was compared.Nerve conduction velocities(SNCV and MNCV),oxidative stress(MDA and SOD),VAS score and TSS score were statistically analyzed in the two groups before and after treatment,and the occurrence of adverse reactions were recorded.Results:The total effective rate of the observation group was significantly higher than that of the control group93.34%(28/30)vs 73.34%(22/30)](P<0.05).The SNCV and MNCV in the two groups after treatment were better than those before treatment(P<0.05),and the conduction velocities of SNCV and MNCV in the observation group were better than those in the control group(P<0.05).The MDA and SOD in the two groups after treatment were better than those before treatment(P<0.05),and the MDA and SOD in the observation group were better than those in the control group(P<0.05).The scores of VAS and TSS after treatment were lower than those before treatment in the two groups(P<0.05),and the scores of the observation group were lower than those of the control group(P<0.05).There were no obvious adverse reactions in the two groups during treatment.Conclusion:The combination of Lipoic acid and Alprostadil has a significant clinical efficacy in the treatment of T2MD with peripheral neuropathy.The treatment results are superior to the single medication,which can significantly improve the symptoms and corresponding indicators,and will not increase the adverse reactions,and can be promoted.
Keywords:Diabetic neuropathies  Diabetes mellitus  Type 2  Lipoic acid  Alprostadil
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号